Atlas Trials

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Clinical trial NCT07301255 · RECRUITING

Trial details

NCT number
NCT07301255
Sponsor
Enveda Therapeutics
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2026-01-09
Primary completion
2026-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.